Rong Li Lab reports protein interactions of MAP kinase signali...(r techniques will become increasingly im...)
Navigation Links
Rong Li Lab reports protein interactions of MAP kinase signaling pathway
Date:12/13/2007
r techniques will become increasingly important to our ability to better understand the most fundamental events in the life cycle of a cell.
'/>"/>
| Contact: Marie Jennings mfj@stowers-institute.org 816-926-4015 Stowers Institute for Medical Research Source:Eurekalert |
Related biology news :
1. BIO-key Reports Second Quarter 2007 Results
2. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
3. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
4. BIO-key Reports Third Quarter 2007 Results
5. WHRC releases 4 key reports
6. Protein chatter linked to cancer activation
7. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
8. Researchers identify proteins involved in new neurodegenerative syndrome
9. Low levels of key protein may indicate pancreatic cancer risk
10. Structure of 450 million year old protein reveals evolutions steps
11. Scientists retrace evolution with first atomic structure of an ancient protein
Post Your Comments:
Breaking Biology News(10 mins):White, but not pure 2White, but not pure 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Stem cells battle for space 2Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial 4995 1Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial 4995 2Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial 4995 3Routine Testing Would Improve Herceptin Use in Breast Cancer 57020 1National Certification for Medical Interpreters Public Call for Final Written Pilot Exam 57018 1National Certification for Medical Interpreters Public Call for Final Written Pilot Exam 57018 2
Other Biology News:Scientists learn structure of enzyme in unusual virus 2Films of Mitchell and Kenyon illuminate lefties' decline in Victorian England 2
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3
[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology[0] Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer[0] EUCODIS Bioscience Appoints Thomas Fischer as New CEO[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Other Biology Technology:NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting 2Korean Food and Drug Administration Approval for ActiPatch Achieved 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |